Biblio

Export 3285 results:
Author Title Type [ Year(Asc)]
Filters: Filter is   [Clear All Filters]
2024
J. M. Chandler, Ye, W., Mi, X., Doty, E. G., and Johnston, J. A., “Potential Impact of Slowing Disease Progression in Early Symptomatic Alzheimer's Disease on Patient Quality of Life, Caregiver Time, and Total Societal Costs: Estimates Based on Findings from GERAS-US Study.”, J Alzheimers Dis, vol. 100, no. 2, pp. 563-578, 2024.
L. Zuo, Hu, Y., Dong, Y. H., Seet, R. Cs, Li, Z., Wang, Y., and Zhao, X., “Pre-existing dementia is associated with 2-3 folds risk for in-hospital mortality and complications after intracerebral hemorrhage stroke.”, J Alzheimers Dis, vol. 102, no. 2, pp. 338-346, 2024.
H. Kim, Le, B., Goshi, N., Zhu, K., Grodzki, A. Cristina, Lein, P. J., Zhao, M., and Seker, E., “Primary cortical cell tri-culture to study effects of amyloid-β on microglia function and neuroinflammatory response.”, J Alzheimers Dis, vol. 102, no. 3, pp. 730-741, 2024.
C. Cressot, Vrillon, A., Lilamand, M., Francisque, H., Méauzoone, A., Hourregue, C., Dumurgier, J., Marlinge, E., Paquet, C., and Cognat, E., “Psychosis in Neurodegenerative Dementias: A Systematic Comparative Review.”, J Alzheimers Dis, vol. 99, no. 1, pp. 85-99, 2024.
O. Snytnikova, Telegina, D., Savina, E., Tsentalovich, Y., and Kolosova, N., “Quantitative Metabolomic Analysis of the Rat Hippocampus: Effects of Age and of the Development of Alzheimer's Disease-Like Pathology.”, J Alzheimers Dis, vol. 99, no. s2, pp. S327-S344, 2024.
A. J. Espay, Herrup, K., Imbimbo, B. P., Kepp, K. P., and Daly, T., “Recalibrating the Risk-Benefit Profiles of Lecanemab and Donanemab: Scales, Immunoreactivity, and Changes in Amyloid-β42.”, J Alzheimers Dis, vol. 99, no. 3, pp. 877-881, 2024.
P. Sachdeva, Narayanan, K. Badri, Sinha, J. Kumar, Gupta, S., Ghosh, S., Singh, K. Kumar, Bhaskar, R., Almutary, A. G., Zothantluanga, J. H., Kotta, K. Kumar, Nelson, V. Kumar, Paiva-Santos, A. Cláudia, Abomughaid, M. Mohammad, Kamal, M., Iqbal, D., ALHarbi, M. Hamoud, ALMutairi, A. Aedh, Dewanjee, S., Nuli, M. Vamsi, Vippamakula, S., Jha, S. Kumar, Ojha, S., and Jha, N. Kumar, “Recent Advances in Drug Delivery Systems Targeting Insulin Signalling for the Treatment of Alzheimer's Disease.”, J Alzheimers Dis, vol. 98, no. 4, pp. 1169-1179, 2024.
K. Ishii, Yamada, T., Hanaoka, K., Kaida, H., Kojita, Y., Kono, A., Hanada, K., Saigoh, K., Sakuta, S., Hashimoto, M., Kato, T., and Nakamura, A., “Regional differences in glucose metabolic decline and tau deposition in the Alzheimer's continuum brain.”, J Alzheimers Dis, vol. 102, no. 1, pp. 228-236, 2024.
H. Stevens Smith, Robinson, J. O., Levchenko, A., Pereira, S., Pascual, B., Bradbury, K., Arbones, V., Fong, J., Shulman, J. M., McGuire, A. L., and Masdeu, J., “Research Participants' Perspectives on Precision Diagnostics for Alzheimer's Disease.”, J Alzheimers Dis, vol. 97, no. 3, pp. 1261-1274, 2024.
C. Marr, McDowell, B., Holmes, C., Edwards, C. J., Cardwell, C., McHenry, M., Meenagh, G., Teeling, J. L., and McGuinness, B., “The RESIST Study: Examining Cognitive Change in Rheumatoid Arthritis Patients with Mild Cognitive Impairment Being Treated with a TNF-Inhibitor Compared to a Conventional Synthetic Disease-Modifying Anti-Rheumatic Drug.”, J Alzheimers Dis, vol. 99, no. 1, pp. 161-175, 2024.
Y. Okinaka, Shinagawa, Y., Claussen, C., Gul, S., Matsui, I., Matsui, Y., and Taguchi, A., “RNA Analysis of Circulating Leukocytes in Patients with Alzheimer's Disease.”, J Alzheimers Dis, vol. 97, no. 4, pp. 1673-1683, 2024.
M. Safieh, Liraz, O., Ovadia, M., and Michaelson, D., “The Role of Impaired Receptor Trafficking in Mediating the Pathological Effects of APOE4 in Alzheimer's Disease.”, J Alzheimers Dis, vol. 97, no. 2, pp. 753-775, 2024.
G. Alva, Cubała, W. J., Berrio, A., Coate, B., Abler, V., and Pathak, S., “Safety Profile of Pimavanserin Therapy in Elderly Patients with Neurodegenerative Disease-Related Neuropsychiatric Symptoms: A Phase 3B Study.”, J Alzheimers Dis, vol. 98, no. 1, pp. 265-274, 2024.
S. Duchesne, Rousseau, L. - S., Belzile-Marsolais, F., Welch, L. - A., Cournoyer, B., Arseneau, M., Lapierre, V., Poulin, S. - M., Potvin, O., and Hudon, C., “A Scoping Review of Alzheimers Disease Hypotheses: An Array of Uni- and Multi-Factorial Theories.”, J Alzheimers Dis, vol. 99, no. 3, pp. 843-856, 2024.
P. Y. Ng, Zhang, C., Li, H., and Baker, D. J., “Senescence Targeting Methods Impact Alzheimer's Disease Features in 3xTg Mice.”, J Alzheimers Dis, vol. 97, no. 4, pp. 1751-1763, 2024.
F. H. Duits, Nilsson, J., Zetterberg, H., Blennow, K., van der Flier, W. M., Teunissen, C. E., and Brinkmalm, A., “Serial Cerebrospinal Fluid Sampling Reveals Trajectories of Potential Synaptic Biomarkers in Early Stages of Alzheimer's Disease.”, J Alzheimers Dis, vol. 100, no. s1, pp. S103-S114, 2024.
C. E. Johnson, Duncan, M. J., and M Murphy, P., “Sex and Sleep Disruption as Contributing Factors in Alzheimer's Disease.”, J Alzheimers Dis, vol. 97, no. 1, pp. 31-74, 2024.
K. Duff, Hammers, D. B., Koppelmans, V., King, J. B., and Hoffman, J. M., “Short-Term Practice Effects on Cognitive Tests Across the Late Life Cognitive Spectrum and How They Compare to Biomarkers of Alzheimer's Disease.”, J Alzheimers Dis, vol. 99, no. 1, pp. 321-332, 2024.
D. Gohel, Zhang, P., Gupta, A. Kumar, Li, Y., Chiang, C. - W., Li, L., Hou, Y., Pieper, A. A., Cummings, J., and Cheng, F., “Sildenafil as a Candidate Drug for Alzheimer's Disease: Real-World Patient Data Observation and Mechanistic Observations from Patient-Induced Pluripotent Stem Cell-Derived Neurons.”, J Alzheimers Dis, vol. 98, no. 2, pp. 643-657, 2024.
M. Carpi, Fernandes, M., Mercuri, N. Biagio, and Liguori, C., “Sleep Biomarkers for Predicting Cognitive Decline and Alzheimer's Disease: A Systematic Review of Longitudinal Studies.”, J Alzheimers Dis, vol. 97, no. 1, pp. 121-143, 2024.
Y. Huang, Driedonks, T. A. P., Cheng, L., Turchinovich, A., Pletniková, O., Redding-Ochoa, J., Troncoso, J. C., Hill, A. F., Mahairaki, V., Zheng, L., and Witwer, K. W., “Small RNA Profiles of Brain Tissue-Derived Extracellular Vesicles in Alzheimer's Disease.”, J Alzheimers Dis, vol. 99, no. s2, pp. S235-S248, 2024.
K. Kitagawa, Toi, S., Hosoya, M., Seki, M., Yamagishi, S., Hoshino, T., and Yoshizawa, H., “Small Vessel Disease Burden Predicts Incident Dementia and Poor Functional Outcome in Independent Outpatients.”, J Alzheimers Dis, vol. 101, no. 3, pp. 751-760, 2024.
M. J. Angevaare, Pieters, J. A., Twisk, J. W. R., and Van Hout, H. P. J., “Social Activity and Cognitive Decline in Older Residents of Long-Term Care Facilities: A Cohort Study.”, J Alzheimers Dis, vol. 98, no. 2, pp. 433-443, 2024.
A. Payen, Bateman, J. R., Muralidhara, S. Dhanavanth, Sachs, B. C., Cleveland, M., Yang, M., Lockhart, S. N., Craft, S., and Bennett, J. M., “Social support may buffer the effect of ε4 allele on cognition in older adults.”, J Alzheimers Dis, vol. 102, no. 4, pp. 967-974, 2024.
Y. Shin Park, Joo, H. Jin, Jang, Y. Seo, Jeon, H., Park, E. - C., and Shin, J., “Socioeconomic Status and Dementia Risk Among Intensive Care Unit Survivors: Using National Health Insurance Cohort in Korea.”, J Alzheimers Dis, vol. 97, no. 1, pp. 273-281, 2024.

Pages